GYRE THERAPEUTICS INC (GYRE) Stock Analyst Ratings
USA - NASDAQ:GYRE - US4037831033 - Common Stock
8.23 USD
+0.15 (+1.86%)
ChartMill assigns a Buy % Consensus number of 84% to GYRE. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 18.36. This target is 123.09% above the current price.
GYRE was analyzed by 9 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about GYRE.
In the previous month the buy percentage consensus was at a similar level.
GYRE was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-10-10 | Jefferies | Initiate | Buy |
| 2025-08-26 | HC Wainwright & Co. | Initiate | Buy |
GYRE THERAPEUTICS INC / GYRE FAQ
What is the price target for GYRE stock?
9 analysts have analysed GYRE and the average price target is 18.36 USD. This implies a price increase of 123.09% is expected in the next year compared to the current price of 8.23.
What is the consensus rating for GYRE stock?
The consensus rating for GYRE THERAPEUTICS INC (GYRE) is 84.4444 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts cover GYRE THERAPEUTICS INC (GYRE) stock?
The number of analysts covering GYRE THERAPEUTICS INC (GYRE) is 9.